REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2026
Back to search
Official data from USPTO
AMAG PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
03/29/2026
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
08/12/2013
Registration date
03/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2023
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-09-00
First use in commerce
2013-09-00
Drawing code
5
Owner type
16
Owner location
ZUG, CH
Examiner
HAYES, GINA CLARK
Law office
L30
Current location
TMEG LAW OFFICE 103
Mark description
The mark consists of the words "AMAG PHARMACEUTICALS" in stylized type.
Holders and representatives
Holders
COVIS PHARMA GMBH
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Representatives
Laura K. Pitts Buchanan Ingersoll & Rooney PC
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of anemia and pharmaceuticalsmedical imaging agents to aid in the diagnosis of cancer and cardiovascular disease
Class 40
Manufacturing services for others in the field of pharmaceuticals
Class 42
Pharmaceutical drug servicespharmaceutical research and development; medical and scientific researchconducting clinical trials
Publications
History of USPTO decisions and trademark events.
63 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/04/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/01/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/13/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2023
E815
TEAS SECTION 8 & 15 RECEIVED
03/14/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/17/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/17/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/17/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/17/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/23/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/22/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/26/2017
IUAF
USE AMENDMENT FILED
01/13/2017
EISU
TEAS STATEMENT OF USE RECEIVED
01/13/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/28/2016
EX5G
SOU EXTENSION 5 GRANTED
07/27/2016
EXT5
SOU EXTENSION 5 FILED
07/14/2016
EEXT
SOU TEAS EXTENSION RECEIVED
07/14/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/22/2016
EX4G
SOU EXTENSION 4 GRANTED
01/22/2016
EXT4
SOU EXTENSION 4 FILED
01/05/2016
EEXT
SOU TEAS EXTENSION RECEIVED
01/05/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/29/2015
EX3G
SOU EXTENSION 3 GRANTED
07/28/2015
EXT3
SOU EXTENSION 3 FILED
07/21/2015
EEXT
SOU TEAS EXTENSION RECEIVED
07/21/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/12/2015
EX2G
SOU EXTENSION 2 GRANTED
03/11/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/09/2015
EXT2
SOU EXTENSION 2 FILED
01/21/2015
EEXT
SOU TEAS EXTENSION RECEIVED
01/21/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/19/2014
EX1G
SOU EXTENSION 1 GRANTED
07/17/2014
EXT1
SOU EXTENSION 1 FILED
07/17/2014
EEXT
SOU TEAS EXTENSION RECEIVED
07/17/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/21/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2013
PUBO
PUBLISHED FOR OPPOSITION
11/26/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/23/2013
ALIE
ASSIGNED TO LIE
10/22/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2013
DOCK
ASSIGNED TO EXAMINER
10/04/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2013
NWAP
NEW APPLICATION ENTERED
08/15/2013
Continuous trademark protection
Get notified about every new filing that threatens AMAG PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.